EmmanuelleL.WaubantMD

Neurology • San Francisco, CA

Associate Professor, Neurology, UCSF School of Medicine

Join to view full profile

Dr. Waubant is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Waubant's full profile

Already have an account?

Office
1500 Owens St
San Francisco, CA 94158
Phone+1 415-353-2069

Fax+1 415-353-2633

Education & Training

OtherClass of 1986

Certifications & Licensure

CA State Medical License 2003 - 2025

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis Start of enrollment: 2005 May 01
Completed
Phase 2
Neuroprotection With Riluzole Patients With Early Multiple Sclerosis Start of enrollment: 2006 Jul 01
Completed
Phase 2
Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis Start of enrollment: 2011 Oct 01
Completed
Vitamin D Supplementation in Multiple Sclerosis Start of enrollment: 2012 Mar 01
Completed
Phase 3
Adherence in Pediatric Multiple Sclerosis Start of enrollment: 2013 Jan 01
Completed
Not Applicable
Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis Start of enrollment: 2022 Feb 16
Recruiting
Phase 2
Roles: Sponsor-Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States.
Elizabeth Wilson, Huong D Meeks, Bradley J Barney, Michael Waltz, Katia Canenguez
Neurology. 2024-12-10
Restoring the Multiple Sclerosis Associated Imbalance of Gut Indole Metabolites Promotes Remyelination and Suppresses Neuroinflammation.
Larissa Jank, Saumitra S Singh, Judy Lee, Asmita Dhukhwa, Fatemeh Siavoshi
Biorxiv. 2024-10-28
Differential Diagnosis of Suspected Multiple Sclerosis in Pediatric and Late-Onset Populations: A Review.
Le H Hua, Andrew J Solomon, Silvia Tenembaum, Antonio Scalfari, Àlex Rovira
JAMA Neurology. 2024-09-16

Journal Articles

Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
Jerry S Wolinsky, Lauren Krupp, Emmanuelle Waubant, Tanuja Chitnis, Brenda Banwell, Kevin Rostasy, The New England Journal of Medicine

Press Mentions

Two Decades of Soldiers’ Medical Records Implicate Common Virus in Multiple SclerosisJanuary 13th, 2022
Can Sunshine Help Prevent MS in Children?December 16th, 2021
Could Exposure to Sunlight Reduce MS Risk in Children?December 14th, 2021
Join now to see all

Other Languages

French